2-Dec-2008

Subscription Info | Institutional Access | Browse the Faculties | Free Trial | Take a Tour | Top 10s | Advanced Search | Faculty Member List | About

Search   All F1000 MedicineNeurological Dis...Multiple Scleros...         Browse ALL OF MEDICINE Neurological Disorders Cerebrovascular Disease Cognitive Neurology & Dementia Developmental & Pediatric Neurology Epilepsy Headache Infectious Diseases of the Nervous System Movement Disorders Multiple Sclerosis & Related Disorders Neuro-Oncology Neuro-Ophthalmology & Neuro-Otology Neurogenetics Neuroimaging Neuromuscular Diseases Neurorehabilitation & CNS Trauma Peripheral Neuropathies Related Sections Alzheimer's Disease Disorders of Neurogastroenterology & Motility Neuro-Endocrinology & Pituitary Neurological Problems in Critical Care Neuropsychiatric Disorders Pain Management: Acute Clinical Pain Management: Chronic Clinical Pain: Basic Science Schizophrenia & Other Psychoses selected for My F1000 Medicine

Browse > Neurological Disorders > Multiple Sclerosis & Related Disorders Current Top 10 by F1000 Factor / All Time Top 10 by F1000 Factor / Most viewed (from all journals) / Most viewed (from specialty journals) / Hidden jewels Page 1 of 6. Select Page: 1 2 3 4 5 6 >> Display 10 / 20 / 50 papers per page printer friendly  10 per page20 per page50 per pageany datepast 7dpast 14dpast 30dpast 60dpast 90dpast 180dpast 1ypast 2ypast 5yall papershypothesesnew findingsconfirmationstech advancescontroversialrefutationdissentingnew on F1000newly evaluatedF1000 factormost evaluations this pageselected articlesto EndNoteRef. ManagerRefWorksBibtexProCite email [Help] Must Read F1000 Factor 6.0 New Finding Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. The CAMMS223 Trial Investigators, Coles AJ, …, Norris K, Tandon PK N Engl J Med 2008 Oct 23 359:1786-801 [abstract on PubMed] [related articles] [order article] Selected by | Richard Ransohoff with Paolo Muraro Evaluated 24 Nov 2008 Recommended F1000 Factor 3.0 New Finding Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale. Bakshi R, Neema M, …, Guttmann CR, Weiner HL Arch Neurol 2008 Nov 65(11):1449-53 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Franz Fazekas with Christian Enzinger Evaluated 24 Nov 2008 Recommended F1000 Factor 3.0 Confirmation New Finding Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis. Lonigro A, Devaux JJ Brain 2008 Oct 25 [abstract on PubMed] [related articles] [full text] Selected by | Kazim Sheikh with Helmar Lehmann Evaluated 24 Nov 2008 Must Read F1000 Factor 6.0 New Finding Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Segal BM, Constantinescu CS, …, Kasper LH, Ustekinumab MS Investigators Lancet Neurol 2008 Sep 7(9):796-804 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Roland Martin with Manuel Friese Evaluated 14 Nov 2008 Recommended F1000 Factor 3.0 Confirmation Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E, Lee JC, Nakamura K, Rudick RA Ann Neurol 2008 Sep 64(3):255-65 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Marco Rovaris Evaluated 7 Nov 2008 Recommended F1000 Factor 3.0 New Finding Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2. Hinson SR, Roemer SF, …, Pittock SJ, Lennon VA J Exp Med 2008 Oct 27 205(11):2473-81 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Charlotte Teunissen Evaluated 6 Nov 2008 Recommended F1000 Factor 3.0 New Finding Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Kidd BA, Ho PP, …, Steinman L, Robinson WH Arthritis Res Ther 2008 Sep 30 10(5):R119 [abstract on PubMed] [related articles] [FREE full text] Selected by | Rene Toes with Leendert Trouw Evaluated 3 Nov 2008 Recommended F1000 Factor 3.0 Hypothesis Improving gait in multiple sclerosis using robot-assisted, body weight supported treadmill training. Lo AC, Triche EW Neurorehabil Neural Repair 2008 Nov-Dec 22(6):661-71 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Robert Ruff Evaluated 3 Nov 2008 Must Read F1000 Factor 6.0 New Finding Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Han MH, Hwang SI, …, Han DK, Steinman L Nature 2008 Feb 28 451(7182):1076-81 [abstract on PubMed] [related articles] [full text] [order article] Selected by | Valder Arruda Evaluated 3 Nov 2008 Recommended F1000 Factor 3.0 Confirmation Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab. Martin MD, Cravens PD, …, Kleinschmidt-Demasters BK, Stüve O Arch Neurol 2008 Oct 13 [abstract on PubMed] [related articles] [full text] Selected by | Timothy Vollmer Evaluated 20 Oct 2008 top of page Page 1 of 6. Select Page: 1 2 3 4 5 6 >> Display 10 / 20 / 50 papers per page

---

© 2008 Medicine Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info